EuroAPI CEO steps down; Samsung Biologics looks to Europe; Merck recalls pneumococcal vaccines

Wel­come to End­points News’ man­u­fac­tur­ing news briefs, where we bring you es­sen­tial up­dates on new builds, col­lab­o­ra­tions, re­calls, and more.

This week, we look in­to Eu­roAPI an­nounc­ing its CEO Karl Rot­thi­er will step down by the end of the month, as well as Sam­sung Bi­o­log­ics and Kur­ma col­lab­o­rat­ing on a mul­ti-year agree­ment to de­vel­op bi­o­log­ics. We al­so note Mer­ck’s re­call of its Vaxneu­vance vac­cine, as well as the launch of a new CD­MO, Ave­na­cy.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.